Literature DB >> 31610317

Laparoscopic Excision of a 5-cm Retroaortic Relapse of Ovarian Cancer.

Stefano Uccella1, Pier Carlo Zorzato1, Enzo Forliti1, Davide Gallina1, Gabriele Lanzo2.   

Abstract

OBJECTIVE: To demonstrate the feasibility of laparoscopic secondary cytoreduction of isolated lymph node relapse of ovarian carcinoma.
DESIGN: A video explanation of a safe excision of ovarian cancer relapse using pictures to show the anatomic landmark of the retroperitoneum guiding the procedure.
SETTING: Department of Obstetrics and Gynecology, Ospedale degli Infermi Hospital, Biella, Italy. The video was approved by the local institutional review board.
INTERVENTIONS: A 61-year-old woman was referred to our center after the diagnosis of a 5-cm bilobate lumbo-aortic relapse of ovarian cancer, 15 months after comprehensive primary surgery, performed in another center by laparotomy and chemotherapy for a stage IIIA2 disease [1-4]. By laparoscopy, extensive adhesiolysis between the small bowel and abdominal wall was performed, showing a peritoneal cavity without any signs of carcinomatosis or disease spread. The laparoscopic operation continued with opening of the preaortic retroperitoneum and exposure of the major vessels, the psoas muscles, and the ureters. The disease relapses were identified as 2 confluent bulky nodal tissues on the left and posterior aspect of the aorta. Complete laparoscopic excision of the 2 masses was achieved. Postoperative course was uneventful, and the patient was discharged from the hospital 2 days after the surgery. Final pathological examination revealed that the 2 masses removed consisted of a total of 10 and 7 metastatic nodes, respectively. The patient initiated postoperative platinum-based chemotherapy 3 weeks after the surgery, and at present, 13 months after the operation, computed tomography scan is negative, and she is free of the disease.
CONCLUSION: Laparoscopic approach to isolated relapse of ovarian cancer is feasible and safe, with fast recovery.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31610317     DOI: 10.1016/j.jmig.2019.09.789

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  3 in total

Review 1.  Laparotomy vs. minimally invasive surgery for ovarian cancer recurrence: a systematic review.

Authors:  Stefano Uccella; Massimo P Franchi; Stefano Cianci; Pier Carlo Zorzato; Francesca Bertoli; Salvatore Gueli Alletti; Fabio Ghezzi; Giovanni Scambia
Journal:  Gland Surg       Date:  2020-08

Review 2.  The robotic single-port platform for gynecologic surgery: a systematic review of the literature and meta-analysis.

Authors:  Vito Andrea Capozzi; Giulia Armano; Andrea Rosati; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2020-05-29

3.  Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer.

Authors:  Zhenying Gong; Sugui Han; Chunlei Zhang; Honghuan Zhao; Jinxia Xu; Xing Sun
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.